Difference between revisions of "Part:BBa K5136233"

Line 11: Line 11:
 
We used <partinfo>BBa_K081005</partinfo> to construct the expression system and obtained the composite <partinfo>BBa_K5136233</partinfo>, which is assembled on the expression vector pSB3K3 by standard assembly. The constructed plasmid was transformed into <i>E. coli</i> BL21(DE3), then the positive transformants were selected by kanamycin and confirmed by colony PCR and sequencing.<br>
 
We used <partinfo>BBa_K081005</partinfo> to construct the expression system and obtained the composite <partinfo>BBa_K5136233</partinfo>, which is assembled on the expression vector pSB3K3 by standard assembly. The constructed plasmid was transformed into <i>E. coli</i> BL21(DE3), then the positive transformants were selected by kanamycin and confirmed by colony PCR and sequencing.<br>
  
===Characterization===
 
====1. Double transformation====
 
We used double transformation to prove the monorhamnoolipid production. Plasmid <partinfo>BBa_K5136233</partinfo>_pSB3K3 and plasmid <partinfo>BBa_K5136232</partinfo>_pSB1C3 were transformed into <i>E. coli</i> BL21(DE3). The positive transformants were selected by kanamycin and chloramphenicol.<br>
 
  
 
===Reference===
 
===Reference===

Revision as of 05:59, 29 September 2024


J23100-rfbD-B0015
Responsible for expression of rfbD facilitated rhlABrhlC to enhance di-rhamnolipids accumulation.(1)

Biology

Studies have shown a limited amount of precursors hinder rhamnolipids production.(2) So over-expression of rfbD can circumvent the shortage of dTDP-l-rhamnose in E. coli. In our project, the rfbD gene controlled by the constant promoter BBa_J23100 and the RBS BBa_B0034 as well as the terminator BBa_B0015 was assembled into the bacterial expression vector pSB3K3 and transformed into E. coli BL21(DE3).


Usage

We used BBa_K081005 to construct the expression system and obtained the composite BBa_K5136233, which is assembled on the expression vector pSB3K3 by standard assembly. The constructed plasmid was transformed into E. coli BL21(DE3), then the positive transformants were selected by kanamycin and confirmed by colony PCR and sequencing.


Reference

1.Du, J., A. Zhang, J. a. Hao, J. Wang (2017). "Biosynthesis of di-rhamnolipids and variations of congeners composition in genetically-engineered Escherichia coli." Biotechnol. Lett 39(7): 1041-1048.
2.Cabrera-Valladares, N. et al. (2006). "Monorhamnolipids and 3-(3-hydroxyalkanoyloxy) alkanoic acids (HAAs) production using Escherichia coli as a heterologous host." Appl. Microbiol. Biotechnol. 73(1): 187-194.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 30
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]